Oblend Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Oblend General Information

Description

Developer of therapeutic plant-based ingredients designed to facilitate the mixing and dispensing of botanical oils. The company's ingredients are used for mixing and dispensing botanical oils to create customized oil blends for on-demand, precise, and single-use consumption, enabling medical professionals to develop their own shampoos, vitamins and perfumes.

Contact Information

Website
www.oblend.com
Formerly Known As
Altopa
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 303 Dunwoody Drive
  • Raleigh, NC 27615
  • United States
+1 (206)
Primary Industry
Other Devices and Supplies
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 303 Dunwoody Drive
  • Raleigh, NC 27615
  • United States
+1 (206)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oblend Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 14-Jan-2026 Completed Generating Revenue
3. Accelerator/Incubator 09-Aug-2021 Completed Generating Revenue
2. Seed Round 28-Dec-2018 $3.76M $5.16M Completed Generating Revenue
1. Seed Round 25-Jul-2017 $1.4M $1.4M Completed Generating Revenue
To view Oblend’s complete valuation and funding history, request access »

Oblend Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-2
Seed
To view Oblend’s complete cap table history, request access »

Oblend Patents

Oblend Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230390310-A1 Personalized, precise, consistent botanical formulations on demand Pending 03-Jun-2022
CA-3171615-A1 Precision control and characterization of dispensed substances Pending 13-Mar-2020
EP-4117492-A1 Precision control and characterization of dispensed substances Inactive 13-Mar-2020
US-12524026-B2 Precision control and characterization of dispensed substances Active 13-Mar-2020
US-20230046651-A1 Precision control and characterization of dispensed substances Active 13-Mar-2020 A47J36/321
To view Oblend’s complete patent history, request access »

Oblend Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oblend Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
WTIA Startup Program Accelerator/Incubator
To view Oblend’s complete investors history, request access »

Oblend FAQs

  • When was Oblend founded?

    Oblend was founded in 2016.

  • Where is Oblend headquartered?

    Oblend is headquartered in Raleigh, NC.

  • What is the size of Oblend?

    Oblend has 4 total employees.

  • What industry is Oblend in?

    Oblend’s primary industry is Other Devices and Supplies.

  • Is Oblend a private or public company?

    Oblend is a Private company.

  • What is Oblend’s current revenue?

    The current revenue for Oblend is .

  • How much funding has Oblend raised over time?

    Oblend has raised $5.16M.

  • Who are Oblend’s investors?

    WTIA Startup Program has invested in Oblend.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process